UNIGE document Scientific Article
previous document  unige:11526  next document
add to browser collection

Pluripotent stem cells as new drugs? The example of Parkinson's disease

Authors show hidden authors show all authors [1 - 11]
Published in International Journal of Pharmaceutics. 2009, vol. 381, no. 2, p. 113-121
Abstract Cell replacement therapy is a widely discussed novel concept of medical treatment. The increased knowledge in the stem cell field, particularly pluripotent stem cells, potentially provides powerful tools for this therapeutic concept. A large number of disease characterized by the loss of functional cells are potential candidates for cell replacement therapy and, in this regards, Parkinson's disease is of particular interest. It is one of the most prevalent neurodegenerative diseases caused by the loss of dopaminergic neurons in the Substantia nigra pars compacta. Pharmacological therapies are valuable but suffer from the progressive decline of efficacy as the disease progresses. Cell therapy application has emerged about two decades ago as a valid therapeutic alternative and recent advances in stem cell research suggest that pluripotent stem cell transplantation may be a promising approach to replace degenerated neurons in Parkinson's disease. Various sources of pluripotent stem cells (PSC) currently tested in animal models of Parkinson's disease have proven their efficacy in relieving symptoms and restoring damaged brain function. This review summarizes and discusses the important challenges that actually must be solved before the first studies of PSC transplantation can be undertaken into humans.
Keywords AnimalsCell DifferentiationHumansParkinson Disease/ therapyPluripotent Stem Cells/ transplantation
PMID: 19782880
Full text
Research groups Groupe Pierre Burkhard (neurologie) (154)
Etude de l'anatomie fonctionnelle des processus cognitifs supérieurs (3)
Mécanismes de différentiation cellulaire des cellules cardiaques (536)
Transplantation immunologie et osteoimmunologie (561)
Radicaux libres et cellules souches embryonnaires (60)
Groupe Schaller Karl Lothard (neurochirurgie) (851)
Imagerie de la transmission dopaminergique dans les troubles addictifs (989)
(ISO format)
PREYNAT-SEAUVE, Olivier et al. Pluripotent stem cells as new drugs? The example of Parkinson's disease. In: International Journal of Pharmaceutics, 2009, vol. 381, n° 2, p. 113-121. doi: 10.1016/j.ijpharm.2009.03.003 https://archive-ouverte.unige.ch/unige:11526

524 hits



Deposited on : 2010-08-27

Export document
Format :
Citation style :